Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Sickle Cell Disease - Stroke Prevention in Nigeria Trial (SPIN)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
National Institutes of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)
Aminu Kano Teaching Hospital
Information provided by (Responsible Party):
Michael DeBaun, Vanderbilt University
ClinicalTrials.gov Identifier:
NCT01801423
First received: February 26, 2013
Last updated: July 21, 2016
Last verified: July 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: September 2021
  Estimated Primary Completion Date: September 2021 (Final data collection date for primary outcome measure)